TECNIS® Symfony IOL

Tecnis Symfony IOLThe latest addition to the TECNIS® Family of IOLs offers new optical technology for providing an Extended Range of Vision. Introducing TECNIS® Symfony IOL, the first and only presbyopia-correcting extended range of vision IOL, available in both a Non-Toric version and a Toric version for patients with astigmatism.

The new lens, the Tecnis Symfony IOL, gives patients with cataracts extended depth of focus to improve vis​ion at any distance, providing continuous vision at all ranges without any drop-offs in between. That's an improvement upon traditional monofocal IOLs, typically designed to improve far-distance vision at the expense of seeing things close up.

In clinical studies, the Symfony lens:

  • Provided seamless, day-to-night vision. Patients could see objects sharply and clearly at near, intermediate and far away distances, and points in between.
  • Provided high-quality vision. Some IOLs may leave patients with an inability to focus clearly due to competing wavelengths of light passing through the lens at different angles (known as chromatic aberration), or with vision that is not completely focused because of the shape of the lens (known as spherical aberration). The Symfony lens has been engineered to correct these issues.
  • Demonstrated a low incidence of halo and glare, which may be perceived as rings or blurring around bright lights. Glare and halo can sometimes affect an individual's ability to drive at night or to perform other visual tasks.

Contact us for more information about our life-changing services. To schedule an appointment, ​please call 8​03-256-0641. More information is also available on the FDA website.

 Spotlight

TECNIS® Symfony IOL
The first and only presbyopia-correcting extended range of vision IOL.
TECNIS® Symfony IOL
button_learnmore

Glaucoma & iStent
iStent works to help control your eye pressure by improving the outflow of fluid from your eyes.
iStent
button_learnmore

Diabetic Eye Disease
Diabetic eye disease is the leading cause of blindness in the 20-64 year age group.
Diabetic Retinopathy
button_learnmore

LenSx® Femtosecond Laser
The LenSx® Laser is the first femtosecond laser cleared by the FDA for use in cataract surgery.
LenSx® Femtosecond Laser
button_learnmore